These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11874953)

  • 21. Rarity of a marked "dawn phenomenon" in diabetic subjects treated by continuous subcutaneous insulin infusion.
    Bending JJ; Pickup JC; Collins AC; Keen H
    Diabetes Care; 1985; 8(1):28-33. PubMed ID: 3971844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoglycemia and counterregulation in insulin-dependent diabetic patients: a comparison of continuous subcutaneous insulin infusion and conventional insulin injection therapy.
    Ng Tang Fui S; Pickup JC; Bending JJ; Collins AC; Keen H; Dalton N
    Diabetes Care; 1986; 9(3):221-7. PubMed ID: 3525052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents.
    Kapellen TM; Heidtmann B; Bachmann J; Ziegler R; Grabert M; Holl RW
    Diabet Med; 2007 Aug; 24(8):836-42. PubMed ID: 17650157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current perspectives on the use of continuous subcutaneous insulin infusion in the acute care setting and overview of therapy.
    Lee SW; Im R; Magbual R
    Crit Care Nurs Q; 2004; 27(2):172-84. PubMed ID: 15137359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cost benefits of intensive insulin therapy using injections, external pumps and implantable pumps].
    Selam JL; Haardt MJ; Berne C; Dorange C; Lanoe JL; Bethoux JP; Slama G
    Diabete Metab; 1993 Dec; 19(5 Suppl):506-9. PubMed ID: 8206188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
    Cummins E; Royle P; Snaith A; Greene A; Robertson L; McIntyre L; Waugh N
    Health Technol Assess; 2010 Feb; 14(11):iii-iv, xi-xvi, 1-181. PubMed ID: 20223123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII.
    Home PD; Capaldo B; Burrin JM; Worth R; Alberti KG
    Diabetes Care; 1982; 5(5):466-71. PubMed ID: 6765222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability].
    Prieto-Tenreiro A; Villar-Taibo R; Pazos-Couselo M; González-Rodríguez M; Casanueva F; García-López JM
    Endocrinol Nutr; 2012 Apr; 59(4):246-53. PubMed ID: 22440045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of continuous subcutaneous insulin infusion in young diabetic patients.
    Levy-Marchal C; Czernichow P
    Diabete Metab; 1988; 14(2):108-13. PubMed ID: 3042484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuous subcutaneous insulin infusion is sometimes a good choice in case of poorly regulated diabetes mellitus type I].
    Hoogma RP; de Vries JH; Michels RP; Hoekstra JB; Levi M
    Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2261-4. PubMed ID: 16240848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous basal insulin infusion without premeal boluses in insulin-dependent diabetes mellitus therapy.
    Cimino A; Valentini U; Rotondi A; Candrina R; Salvi A; Spandrio S; Radaeli E; Giustina G
    Acta Diabetol Lat; 1987; 24(3):193-8. PubMed ID: 3318256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin pump therapy: a meta-analysis.
    Weissberg-Benchell J; Antisdel-Lomaglio J; Seshadri R
    Diabetes Care; 2003 Apr; 26(4):1079-87. PubMed ID: 12663577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathy.
    Chiasson JL; Ducros F; Poliquin-Hamet M; Lopez D; Lecavalier L; Hamet P
    Diabetes Care; 1984; 7(4):331-7. PubMed ID: 6381006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents.
    Hanas R; Ludvigsson J
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():32-8. PubMed ID: 16774616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with discontinuation of continuous subcutaneous insulin infusion.
    Bell DS; Ackerson C; Cutter G; Clements RS
    Am J Med Sci; 1988 Jan; 295(1):23-8. PubMed ID: 3122566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered recognition of hypoglycaemic symptoms in type I diabetes during intensified control with continuous subcutaneous insulin infusion.
    Lager I; Attvall S; Blohmé G; Smith U
    Diabet Med; 1986; 3(4):322-5. PubMed ID: 2949919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial.
    Lawton J; Kirkham J; Rankin D; White DA; Elliott J; Jaap A; Smithson WH; Heller S;
    Diabet Med; 2016 Feb; 33(2):243-51. PubMed ID: 26248590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.